vimarsana.com

Page 140 - பல்கலைக்கழகம் ஆஃப் அலபாமா இல் பர்மிங்காம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

David Parker: UAB Grad putting Theatre Dreams In Motion

David H. Parker’s “big dream” is in motion. Parker will graduate May 1 from the University of Alabama at Birmingham, with a Bachelor of Arts degree in performance and directing from the College of Arts and Sciences’ Department of Theatre. Their next destination is the University of California, Los Angeles, where they will pursue a Master of Fine Arts degree in theater directing on a full scholarship through UCLA’s Graduate Opportunity Fellowship beginning this fall. “Everything I aspired to but never thought I could realistically achieve 10 years ago led to UCLA, and now I’m getting paid to go,” Parker said. “So, by speaking my next big dream into the world, I, too, give that dream a pair of legs and a set of lungs.”

Verona Pharma Reports Results of Pilot Study of pMDI Ensifentrine in U S Patients Hospitalized with COVID-19

Published: Apr 23, 2021 LONDON and RALEIGH, N.C., April 23, 2021 (GLOBE NEWSWIRE) Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces data from a pilot study of a pressurized metered-dose inhaler (“pMDI”) formulation of ensifentrine showed that ensifentrine was safe and well tolerated in patients infected with SARS-CoV-2, the virus that causes COVID-19. The trial was not designed or sized to demonstrate clinical efficacy and no clinical efficacy benefit with ensifentrine treatment added on to standard of care was observed in the trial. One patient death was reported in the ensifentrine treatment group. “Overall, the patients in this study recovered exceptionally well, as the mortality rate in the study was much lower than aggregate data from the hospital would have suggested over the same time period,” commented Mike Wells, MD, a pulmonologist and Principal Investigator at the

Young Investigators Recognized at National Kidney Foundation s 16th Annual National Young Investigators Forum

Young Investigators Recognized at National Kidney Foundation s 16th Annual National Young Investigators Forum News provided by Share this article Share this article NEW YORK, April 29, 2021 /PRNewswire/  Research fellows were recognized for their excellence in basic and clinical research at the annual National Young Investigators Forum (YIF) on April 22 and April 23. Regional winners were invited to participate virtually and compete for national accolades based on original research they presented at the forum. I applaud all the nephrology and post-doctoral fellows who participated in this year s Young Investigators Forum.  Kidney disease has reached epidemic proportions in the United States, affecting 37 million Americans, said Paul Palevsky, MD, FASN, FNKF, National Kidney Foundation President. These young investigators, the future of nephrology research, give us hope that their generation of researchers will find new approaches to decrease the burden of kidney disease a

CDC says many Americans can now go outside without a mask

CDC says many Americans can now go outside without a mask Associated PressMasked and unmasked pedestrians walk along the Las Vegas Strip, Tuesday, April 27, 2021, in Las Vegas. The Centers for Disease Control and Prevention eased its guidelines Tuesday on the wearing of masks outdoors, saying fully vaccinated Americans don t need to cover their faces anymore unless they are in a big crowd of strangers. (AP. By MIKE STOBBE AP Medical Writer NEW YORK (AP) The Centers for Disease Control and Prevention eased its guidelines Tuesday on the wearing of masks outdoors, saying fully vaccinated Americans don’t need to cover their faces anymore unless they are in a big crowd of strangers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.